2020 annual financial data
Rhythm Pharmaceuticals 2020 Net income growth
Direct answer
Net income growth was 2.89%.
Operating income was -136,575,000 USD and net income was -130,727,000 USD.
Operating cash flow was -121,980,000 USD.
Get free Rhythm Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 35,000 USD
- Operating income
- -136,575,000 USD
- Net income
- -130,727,000 USD
- Operating cash flow
- -121,980,000 USD